Cohance Lifesciences Ltd. Share Price

542.55 -6.55 (-1.19%)
Full Screen
Collapse
Cohance Lifesciences is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.

Fundamentals

Market Cap

₹20,649Cr

EPS

₹10.45

Book Value/Share

₹44.68

P/E Ratio (TTM)

67.60

Industry P/E (TTM)

41.20

P/B Ratio

8.23

Long Term D/E

0.16

ROE

14.29%

Dividend Yield (TTM)

0.00%

Factor Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Interpretations Icon

Huge Underperformer

Interpretations Icon

Somewhat Expensive

Interpretations Icon

Excellent Quality

Interpretations Icon

Low Price Fluctuation

Interpretations Icon

Analysts are Very Bearish

Peer Comparison

Peer comparison lists companies from the same sector, scored and ranked based on Factor Analysis. It helps understand how a company stands against its competitors.

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Cohance Lifesciences Ltd.

Cohance Lifesciences Ltd. share price is ₹542.55 as of 05/12/2025, 4:04:52 pm. Share/stock prices are volatile and change over the course of a trading day, and may differ basis on exchange (NSE/BSE).

Cohance Lifesciences Ltd. reported an ROE of 14.29 for the last reported financial year on a consolidated account basis. Return on Equity (ROE) reflects how efficiently the company is able to generate profit as a percent of their equity financing.

Shareholding pattern gives insights on the concentration of holdings towards various groups of investors. As of last reported quarter for Cohance Lifesciences Ltd., Promoter held 57.50%, the FII held 6.50%, DII held 20.80%, and the public held 15.20% of the total shares.

You can easily buy shares of Cohance Lifesciences Ltd. online through Share.Market. If you are an existing user, login to your account, else follow the process to create your own Demat and Trading account in a few easy steps.

The fair value of Cohance Lifesciences Ltd. is an estimated price at which buyers and sellers would freely trade their shares. The various ways to determine the fair value of an asset include looking at recent market transactions for similar assets, estimating its expected earnings or the cost of replacing it.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

No data

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

No data

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

No data

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages0

Bearish Moving Averages16

5 Day

551.10

10 Day

561.80

20 Day

601.40

30 Day

667.70

50 Day

753.50

100 Day

859.80

150 Day

918.60

200 Day

976.50

Indicators

Indicators
Technical indicators use historical price and volume data to help predict future price movements.

RSI (14)

19.17

MACD (12, 26)

-62.23

MACD Signal Line (9)

-66.44

MFI (14)

24.91

ATR (14)

20.86

ADX (14)

61.30

ROC (21)

-26.07

ROC (125)

-48.38

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

No data

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

stock-icon
Cohance Lifesciences Ltd.
542.55 (-1.19% )
stock-icon

Cohance Lifesciences Ltd.

COHANCE

542.55
-6.55 (-1.19% )1D

Open Price

546.50

Prev Close

549.10

Upper Circuit

658.90

Lower Circuit

439.30

Volume

3,45,767

Average Traded Price

541.21
533.55Today's Low
548.90Today's High
533.5552W Low
1,342.0052W High
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.